FDA is not bound by the Hippocratic oath the way physicians are
Preclinical and clinical studies demonstrate that co-administration of these peptides achieves superior reductions in bodyweight, appetite, and fasting glucose than either agent aloneachieving up to a 17% reduction in bodyweight in non-diabetic individuals and a 15.6% reduction in patients with type 2 diabetes over 2032 weeks
Metabolic pathway research, adipocyte behavior studies, mitochondrial efficiency analysis, and NAD+-related biochemical investigations
Ingredient Quantity Cyanocobalamin (Vitamin B12) 1000 mcg/mL Sodium Chloride 0.22% w/v Ammonium Sulfate 0.1% w/v Citric Acid 0.01% w/v Sodium Citrate 0.008% w/v Benzyl Alcohol (Preservative) 1.0% v/v
Research shows injectable GHK-Cu can increase collagen I production by up to 70% in dermal fibroblasts and boost elastin synthesis by 30% across all tested concentrations
She will create a personalized treatment plan for you, administering this powerful antioxidant intravenously to ensure maximum absorption and effectiveness